Literature Citations Close

Literature Citations for OriGene clone representing NM_000245


NPS-1034, a novel MET inhibitor, inhibits the activated MET receptor and its constitutively active mutants, Shin, JS;Hong, SW;Moon, JH;Kim, JS;Jung, KA;Kim, SM;Lee, DH;Kim, I;Yoon, SJ;Lee, CG;Choi, EK;Lee, JY;Kim, KP;Hong, YS;Lee, JL;Kim, B;Choi, EK;Lee, JS;Jin, DH;Kim, TW;, Invest New Drugs. 2013 Oct 31

Insights into ALK-Driven Cancers Revealed through Development of Novel ALK Tyrosine Kinase Inhibitors, Christine M. Lovly, Johannes M. Heuckmann, Elisa de Stanchina, Heidi Chen, Roman K. Thomas, Chris Liang, and William Pao, Cancer Res., Jul 2011; 71: 4920 - 4931.

MET Receptor Sequence Variants R970C and T992I Lack Transforming Capacity, Jeffrey W. Tyner, Luke B. Fletcher, Ellen Q. Wang, Wayne F. Yang, Michael L. Rutenberg-Schoenberg, Carol Beadling, Motomi Mori, Michael C. Heinrich, Michael W. Deininger, Brian J. Druker, and Marc M. Loriaux, Cancer Res., Aug 2010; 70: 6233 - 6237

Structural basis for a novel intrapeptidyl H-bond and reverse binding of c-Cbl-TKB domain substrates, Cherlyn Ng, Rebecca A Jackson, Jan P Buschdorf, Qingxiang Sun, Graeme R Guy, J Sivaraman, The EMBO Journal 27, 804 - 816 (05 Mar 2008),